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Objective: To report our experience in the selection of newborns 
candidate to therapeutic hypothermia. Methods: Retrospective 
study involving 47 newborns suffering from perinatal asphyxia 
from January 2008 to September 2011. Results: Thirty-five of 
47 newborns admitted to our hospital fulfilled metabolic and 
neurological criteria for recruitment and were cooled. aEEG 
was carried out in 26 of them and resulted always abnormal. 
In three of the 12 newborns with only metabolic criteria, 
aEEG was moderately abnormal. They were cooled and their 
outcome (evaluated by General Movements and Griffiths 
Mental Development Scales for children aged 0–2 years) is 
good. Three additional newborns who only met the metabolic 
criterion reached our hospital after the therapeutic window 
for hypothermia and exhibited seizures; their outcome is poor. 
Conclusions: In our experience, the inclusion of aEEG in the entry 
criteria would not have precluded newborns with neurological 
criteria from cooling. On the contrary, without an early aEEG, we 
would have excluded from hypothermia infants with moderate 
hypoxic-ischemic encephalopathy without precocious neuro-
logical signs who exhibited only the metabolic criterion, but 
with abnormal aEEG. If further studies will confirm that early 
aEEG might identify newborns suitable for cooling even in the 
absence of clinical signs, a revision of the entry criteria should be 
considered.
Keywords: asphyxia, hypoxic-ischemic encephalopathy, 
neuroprotection, newborn
Abbreviations: aEEG: amplitude integrated EEG; Cho: choline;  
Cr: creatine phosphocreatine; DQ: developmental quotient; 
GMDS: Griffiths Mental Development Scales; GMs: general 
movements; HIE: hypoxic-ischemic encephalopathy;  
MRI: magnetic resonance imaging; NAA: N-acetylaspartate; 
NICU: neonatal intensive care unit; SD: standard deviations
Introduction
Perinatal asphyxia complicated by moderate or severe hypoxic-
ischemic encephalopathy (HIE) is one of the major causes for 
neonatal death or later neurodevelopmental sequelae [1]. Its 
incidence is estimated to be 3–9 cases out of 1000 live births 
[2]. About 10% of newborns with moderate HIE die and about 
30% of those who survive have neurological impairment. Such 
percentages raise in infants with severe encephalopathy to around 
60 and 100% [3,4]. Selective head cooling or whole-body cooling 
to a target core temperature of 33.5°C for around 72 h, to be 
started within 6 h after birth (the therapeutic window for poten-
tial neurological rescue) [5], is reported to significantly improve 
newborns’ survival and to reduce neurological impairment [6–9]. 
It is therefore essential to identify the candidates for this treat-
ment as soon as possible [10].
The most used entry criteria include a metabolic indication of 
hypoxic-ischemic injury (low Apgar scores and/or persisting need 
for resuscitation and/or severe acidosis) and at least two or three 
clinical neurological findings of neonatal encephalopathy (altered 
state of consciousness, abnormalities of tone, reflexes, posturing, 
autonomic dysfunction and seizures) [5–8], corresponding to 
Sarnat grade 2–3 [11].
The amplitude integrated electroencephalography (aEEG) 
has been adopted as entry criteria for the treatment with hypo-
thermia only in a few of the major trials [6,9,12], where the 
newborns treated only after all three major criteria (metabolic, 
neurological and electroencephalographic) were sequentially 
fulfilled. The role of aEEG in selecting newborns for cooling 
remains controversial because of its low predictive value and 
the risk of reserving hypothermia only to newborns with more 
severe asphyxia [13]. However, no study has explored the 
possibility that aEEG could identify newborns with anomalous 
electrographic activity, typical of a moderate encephalopathy, in 
the absence of neurological signs, who, according to standard 
inclusion criteria, would not be cooled.
In this paper, we report our experience with asphyxiated 
newborns hospitalized in our Neonatal Intensive Care Unit 
(NICU), where some newborns admitted with metabolic criterion 
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only exhibited abnormal aEEG. This experience seems to suggest 
that aEEG could be necessary for selecting neonates with HIE who 
would benefit from hypothermia.
In view of this specific experience, we also discuss the potential 
role of an early aEEG evaluation in the identification of candidates 
for the treatment with hypothermia.
Patients and methods
We performed a retrospective cohort study identifying from 
medical records all term newborns (gestational age 37–42 
weeks) admitted to the 16 beds NICU of the A. Meyer University 
Children’s’ Hospital, for perinatal asphyxia, from January 2008 to 
September 2011.
The treatment with therapeutic hypothermia was initially 
reserved to newborns with gestational age ≥36 weeks and birth 
weight ≥1800 g who fulfilled the following two criteria modi-
fied from Sarnat and Sarnat [11]:  (i) metabolic criteria: Apgar 
score ≤5 at 10 min, or persisting need for resuscitation, including 
endotracheal intubation or mask ventilation for more than 10 
min after birth, or acidosis (pH ≤7.0 and/or base deficit ≥−16 
mmol/L in umbilical cord blood or arterial, venous or capil-
lary blood) within 60 min from birth; (ii) neurological criteria: 
moderate to severe encephalopathy consisting of altered state of 
consciousness (irritability, lethargy, stupor or coma) and ≥1 of 
the following signs: hypotonia, or abnormal reflexes including 
oculomotor or pupil abnormalities, or absent or weak suctioning, 
or clinical seizures. Newborns older than 6 h of age at the time 
of evaluation and newborns with major congenital abnormali-
ties, congenital viral infections or evidence encephalopathy other 
than HIE were excluded. Outborn newborns who met both the 
above criteria were initially cooled to around 35°C at their birth 
hospital, by stopping the heating and applying ice packs close to 
their head and body during the transfer to NICU. Upon arrival, 
newborns were evaluated again by skilled and qualified neona-
tologists to evaluate their suitability for therapeutic hypothermia. 
In the presence of both criteria, newborns were cooled to 33.5° 
using a cooling blanket (Blanketrol® III, Hyper-hypothermia 
System, Cincinnati Sub-Zero, Cincinnati, OH, USA), connected 
by a servomechanism with an esophageal probe.
After 72 h of hypothermia, newborns were gradually rewarmed 
to 36.5−37°C by increasing the automatic control set point of 
0.5°C/h. Newborns who fulfilled both entry criteria were enrolled 
until August 2009 in a pilot study that evaluated the safety of oral 
topiramate administration associated to hypothermia [14] and 
those admitted from February 2010 in a randomized controlled 
study evaluating the efficacy of combination treatment with topi-
ramate and hypothermia [15].
From November 2008, all newborns referred to our NICU for 
perinatal asphyxia underwent aEEG recording (BRM 3®, BrainZ 
Instruments, Auckland, New Zealand) more than 20 min, starting 
as soon as they were admitted. The needle electrodes were placed 
bilaterally at the central and parietal positions (according to the 
C3 and P3 on the left and C4 and P4 on the right placement 
on the newborn infant). The definition “moderately abnormal” 
indicates a background tracing with upper margin >10 µV 
and lower margin ≤5 µV; “severely abnormal” pattern refers to 
a tracing with upper margin <10 µV and lower margin <5 µV; 
often, this is accompanied by bursts of high voltage activity 
(“burst suppression”) [16]. Seizures were identified as periods of 
sudden increase in voltage, accompanied by a narrowing of the 
band of aEEG activity followed by a brief period of suppression 
[16] or by a build-up of rhythmic activity of increasing amplitude 
and decreasing frequency. The aEEG recordings obtained during 
the evaluation for the potential cooling were subsequently 
evaluated again for abnormalities by three of the investigators 
(FM, TP and GR) certified to read the aEEG recordings. An 
abnormal aEEG was followed by standard EEG. Both studies 
were approved by the Institutional Review Board, and informed 
consent was obtained from the children’s parents. While for 
newborns enrolled in the prospective trial, a complex neurodevel-
opmental and neuroradiologic follow-up was planned; for those 
who fulfilled only the first metabolic criterion, neurodevelopment 
was evaluated at 3 months of life with the General Movements 
(GMs) [17] and Griffiths Mental Development Scales (GMDS) for 
children aged 0–2 years [18]. The total developmental quotient 
(DQ) and subquotients were calculated. The normal DQ is usually 
evaluated to be 100 ± 13. All infants were assessed by neuropsy-
chiatrists specialized in neurodevelopmental examination and 
who had completed an accredited training course on the GMDS 
(FM, TP and GR). In newborns with abnormal aEEG, a cerebral 
magnetic resonance imaging (MRI) was planned within the first 
week of life and then at the 3rd and 18th month. MRI of the brain 
was performed using a 1.5 T magnet with T1 and T2 weighted 
imaging sequences in the coronal, axial and sagittal planes.
An adverse outcome was defined by an absence of fidgety 
movements at 3 months at the GMs, a DQ <2 standard deviations 
(SD) at GMDS and the presence of brain lesions characteristic 
of HIE at MRI (involvement in the basal ganglia and thalamus, 
Table I. Demographic data and outcome of newborns treated with 
hypothermia.
Newborns treated with hypothermia, n = 35
Male, n (%) 23 (65.7)
Gestational age, weeks, mean ± SD a 38.6 ± 2.6
Birth weight, g, mean ± SD 3168 ± 545
Cesarean section, n (%) 21 (60.0%)
Stained amniotic fluid, n (%) 17 (48.6%)
Outborn, n (%) 35 (100.0%)
Apgar Score, 1 min, mean ± SD 2.0 ± 2.3
Apgar Score, 5 min, mean ± SD 3.9 ± 2.3
Crib score, mean ± SD 4.1 ± 2.0
Arterial pH, mean ± SD 6.855 ± 0.17
Arterial BE, mEq/L, mean ± SD –21.6 ± 7.2
Arterial lactic acid, mmol/l, mean ± SD 16.1 ± 4.4
Hour hypothermia beginning, mean ± SD 3.6 ± 1.3
Survival rate at discharge, n (%) 30 (85.7)
Cerebral magnetic resonance at discharge, n (%) 34 (97.1)
 Normal, n (%) 13 (38.2)
 WM isolated, n (%) 1 (2.9)
 WM+COR, n (%) 0
 BGT isolated, n (%) 12 (35.3)
 BGT+WM, n (%) 2 (5.9)
 BGT+COR, n (%) 1 (2.9)
 BGT+COR+WM, n (%) 5 (14.7)
Neurological evaluation at follow-up, n (%) 34 (97.1%)
Normal 19 (55.9)
Cerebral palsy and developmental delay n (%) 4 (11.8)
Cerebral palsy, developmental delay and epilepsy, n (%) 6 (17.6)
Deceased 5 (14.7)
Not available 1 (2.9%)
aCalculated from maternal menstrual history, obstetrical data or by Ballard’s score.
BE, base excess; BGT, basal ganglia/thalamus; COR, cortex; CRIB, Clinical Risk Index for 
Babies; SD, standard deviation; WM, white matter.
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posterior limb of the internal capsule, subcortical white matter 
and cortical gray matter).
Results
During the period of the study, 47 asphyxiated newborns were 
admitted in our NICU. Thirty-five met both admission criteria 
and were cooled. Demographic data and neurologic outcome of 
these newborns are shown in Table I. aEEG recording was started 
immediately after their admission in 26 of these newborns, at a 
median age of 3.4±1.1 h after birth. A moderately abnormal aEEG 
was detected in 12 newborns (46.2%) and a severely abnormal 
aEEG in 14 (53.8%) (Figure 1). The remaining nine newborns 
were evaluated with a standard EEG that was abnormal in all.
Twelve additional newborns who only exhibited the metabolic 
criteria were transferred within the first 6 h of life to our NICU 
to evaluate their suitability for the treatment with therapeutic 
hypothermia. Two of these neonates exhibited mild respiratory 
distress in the first hours of life, but none required mechanical 
ventilation; none of these infants received sedation, and a detailed 
clinical evaluation confirmed the absence of neurological crite-
rion in all the newborns. Eleven newborns were subjected to 
aEEG. Eight of them exhibited a normal EEG pattern and their 
neurodevelopmental outcome was normal. Three exhibited a 
moderately abnormal EEG pattern and their outcome is discussed 
in the following section. Demographic data of these three patients 
are shown in Table II (patients 1, 2 and 3).
At the arrival in NICU, patient 1 was hyperalert and his aEEG 
is shown in Figure 2. A standard EEG revealed a low voltage path. 
As this electrophysiological finding was consistent with a Sarnat 
grade 2, we decided to cool him. At 12 h, seizures occurred that 
were treated with phenobarbital. Cerebral ultrasounds at 4 days of 
life revealed mild diffuse parenchymal hyperechogenicity; MRI at 
5 days was normal; the spectroscopy study showed a reduction in 
the ratio N-acetilaspartate (NAA)/creatine phosphocreatine (Cr), 
without lactic acid. GMs were normal at 3 months (presence of 
fidgety) and his DQ at the actual age is in the normal range.
Patient 2 showed in the first hours of life only overactive stretch 
reflexes; her aEEG is shown in Figure 2. A standard EEG showed 
a low voltage path with alternating suppression and anterior 
non-reactive irregular activity. As a result of this observation, 
therapeutic hypothermia was started. Cerebral ultrasound at 3 
days showed mild periventricular hyperechogenicity. Brain MRI 
at 5 days showed increased signal intensity in the basal ganglia 
and in the posterior left semioval center. Spectroscopy showed 
a reduction in the pool of NAA, a slight increase in choline 
(Cho)/Cr with lactic acid in the basal ganglia and left semioval 
center. At 3 months, she showed normal GMs, her DQ at the 
actual age is in the normal range and her MRI is actually normal.
Patient 3 was cooled because aEEG was moderately abnormal 
(Figure 2), and standard EEG showed a low voltage and asym-
metric path. At 16 h, seizures required treatment with pheno-
barbital. At her 5th day of life brain, MRI spectroscopy revealed 
lactate in the white matter and in the basal ganglia. Fidgety was 
present at 3 months, her DQ at actual age is in the normal range 
and cerebral MRI is normal.
In the same period, three additional asphyxiated newborns 
were admitted suffering from seizures that had developed after the 
therapeutic window for treatment with hypothermia had passed. 
At the birth hospital, these newborns had been considered non 
suitable for hypothermia because clinical evaluation, carried out 
by not-trained personnel, had failed to detect neurological signs 
of HIE, neither aEEG had been performed. These patients are 
presented in Table II as patients 4, 5 and 6.
Patient 4 was resuscitated at birth, but clinical examination was 
normal in the first hours of life. At 20 h, clonic seizures appeared 
in the lower limbs. EEG showed a series of electrical seizures and 
therapy with phenobarbital was started. At 24 hours of life, she 
was transferred to our NICU. Standard EEG at 28 h showed parox-
ysmal abnormalities. Intravenous phenytoin was added and in the 
eighth day of life EEG improved. Brain MRI at 3 days showed a 
diffuse subcortical white matter and basal ganglia hyperintensity. 
At 3 months, GMs were pathological, with absence of fidgety and 
poor repertoire. Nowadays, he has a pathological DQ (2>SD<3) 
and his cerebral MRI is abnormal.
Figure 1. Patients arrived to our NICU for perinatal asphyxia.
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Patient 5 was neurologically normal in the first hours, but 
she arrived to our NICU at 16 h manifesting seizures that 
were treated with phenobarbital and midazolam. EEG showed 
abnormalities in both central regions and paroxysmal abnor-
malities that were unresponsive to pyridoxine and phenytoin, 
but were attenuated by high doses of midazolam. Brain MRI 
at 12 days showed bilateral frontal and posterior ischemic 
lesions and widespread reduction in the subcortical white 
matter. Fidgety at 3 months was absent and her cerebral MRI 
is still pathological. Her DQ at actual age is out of the normal 
range (SD <3).
Patient 6 was resuscitated at birth, but appeared neurologically 
normal in the first hours of life. Seizures, appeared at 10 h of life, 
were successfully treated with midazolam after failure of pheno-
barbital and phenytoin. EEG showed a discontinuous tracing with 
burst suppression. Brain MRI at 5 days showed frontal, temporal, 
occipital, thalamic ischemic lesions and widespread reduction in 
the subcortical white matter.
Discussion
Therapeutic hypothermia is currently the most effective neuro-
protective strategy for newborns with HIE [6–9,19]. The CoolCap 
Trial demonstrated that cooling was beneficial in the subgroup of 
newborns with moderate aEEG abnormalities [6], typical of Sarnat 
grade 2 [11]. On the contrary, when newborns exhibited severe 
clinical encephalopathy or severely impaired background activity 
on early aEEG, outcome was still likely to be extremely poor [20–
22], despite hypothermia [5,21]. Therefore, it is essential to identify 
the largest number of newborns with a moderate encephalopathy.
Although EEG is useful to identify suitable newborns for 
hypothermia due to its capability to distinguish newborns with 
Sarnat grade 2 from newborns with Sarnat 1 [11], its use in this 
context remains controversial. Several studies have demonstrated 
that aEEG is easier to be interpreted than standard EEG, but 
equally accurate and reproducible [23]. It correlates well with 
neurodevelopmental outcome of full-term infants with HIE 
[13,24,25], and it is considered the best single predictor of 
neurologic outcome [26]. In some studies aEEG was more specific 
and exhibited a higher positive predictive value when compared 
with the neurologic examination performed in the first hours 
after delivery [13]. This finding, together with the observation 
that moderate hypothermia does not affect aEEG amplitude 
[27], could advocate its use in newborns who are at risk of HIE 
for selecting suitable candidates for cooling. This approach was 
adopted in the CoolCap study [6], the TOBY Trial [9] and the 
NeonEuro study [12], where aEEG was employed as a third entry 
criterion, in addition to metabolic and neurological parameters. 
However, in other studies this strategy was considered to be 
misleading because, according to these criteria, mainly the sickest 
newborns suffering from a more serious HIE would be selected 
[28]. The same question has been addressed by Sarkar et al. who 
found a normal or a non-qualifying aEEG in a few newborns 
with metabolic and clinical signs of severe encephalopathy [29]. 
These newborns were not cooled, but a significant part of them 
showed clinical signs and neuroradiologic lesions with severe 
HIE afterwards. According to these authors, aEEG was judged 
not advisable as additional selection criterion because of the 
low negative predictive value in the first hours of life, and other 
important trials did not consider aEEG as a criterion to select 
newborns to be treated with hypothermia [6,7].
In our experience, all patients who fulfilled both metabolic and 
neurological criteria exhibited an abnormal aEEG. Therefore, in 
contrast with the mentioned study, should we have used aEEG 
as entry criteria, we would not have precluded newborns with 
neurological signs of HIE from cooling. On the contrary, without 
an early aEEG, we would have excluded from treatment with 
hypothermia infants exhibiting the metabolic criterion only who, 
however, subsequently demonstrated neurological disorders or 
abnormal aEEG.
Recently, it has been demonstrated that the aEEG is influ-
enced by electrode location and interelectrode space. The ampli-
tude increased linearly and significantly with the interelectrode 
distances [30]. This means that if the electrodes are spaced 
close to each other, the trace could be often outside the voltage 
normal criteria. However, all the reported cases with moderately 
abnormal aEEG also had significantly abnormal EEG trace.
Mild aEEG anomalies were observed in 46.2% of newborns in 
our study, whereas severe anomalies were recorded in 53.8% of the 
cases. These percentages are rather different from those observed 
in the CoolCap study, where most newborns had moderate EEG 
anomalies [6], but are similar to those described in the TOBY trial 
Table II. Demographic and clinical data of the reported newborns.
Patient 1 2 3 4 5 6
Sex M F F M F M
Gestational 
age, weeks
41+1 39+2 38 38 41+2 42+2
Birth weight, g 3690 3350 3000 2565 2500 2890
Type of 
delivery
Sp Sp EC Sp EC Sp
Obstetric risk 
factor
SAF VE and 
SAF
PA and 
HRD
VE SAF HRD
Intubation in 
delivery room
yes yes no yes no No
Apgar Score, 
1 min
3 5 3 4 6 3
Apgar Score, 
5 min
5 5 6 4 6 8
Arterial pH, 
-log(H+)
6.82 6.88 6.84 6.84 6.87 7.09
pCO2, mmHg 93.2 72.3 77.3 24.5 56.6 64
pO2, mmHg 47.5 12.3 97.2 56.7 45.8 25.1
Arterial BE, 
mEq/L
−28.3 −20.3 −19.1 −25.9 −24.4 −16.8
Arterial 
HCO3, 
mmol/L
5.0 7.2 7.4 6.0 7.8 12.2
Arterial lactic 
acid, mmol/L
17.6 11.9 17.4 12.1 10.9 11.2
Clinical 
Seizures 
(hours of life)
12 – 16 20 16 10
Phenobarbital Yes – Yes Yes Yes Yes
Therapeutic 
hypothermia
Cooled Cooled Cooled Not cooledNot cooled Not 
cooled
Actual age 
(months)
18 18 9 26 6 1
Fidgety at 3 
months
present present present absent absent N/A
DQ at GMDS 
(SD)
normal normal normal >2 SD <3 <3 SD N/A
HC (centile) at 
actual age
50° 50–75° 25–50° <3° <3° 25–50°
DQ, developmental quotient; VE, vacuum extractor; EC, emergency cesarean; GMDS, 
Griffiths Mental Development Scales; HC, head circumference; HRD, heart rate 
deceleration; PA, placental abruption; SAF, stained amniotic fluid; Sp, spontaneous.
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[9]. It is quite surprising to find such percentages, since it is highly 
unlikely that the number of cases of severe asphyxia is bigger than 
that of those with moderate asphyxia. These different rates suggest 
that there might be a subset of infants with a moderate encepha-
lopathy that is properly identified with difficulties or remains 
undiagnosed with a clinical examination only. We hypothesize 
that it is simple to identify newborns with severe encephalopathy 
(corresponding to Sarnat grade 3) but it might not be as easy to 
diagnose moderate encephalopathy (corresponding to Sarnat 
grade 2). This difficulty could be due to the fact that clinical signs 
of HIE may take hours to fully develop [29]. In addition, Sarnat 
encephalopathy scoring is a well-validated method of outcome 
prediction only from 24 h of age [11] and newborns’ first neuro-
logical examination at their birth hospitals was carried out by 
noncertified examiners.
One of the more surprising results of our experience was the 
high percentage (27.3%) of newborns with abnormal aEEG in the 
absence of clinical signs.
Clinical and neuroradiologic follow-up of these infants 
suggested that asphyxia was definitely more severe than we had 
thought on the basis of early clinical evaluation. The number 
of newborns with this contradictory picture is still too small 
to draw significant conclusions, although the presence of 
ambiguous signs at the boundary between mild and moderate 
encephalopathy in a significant percentage of newborns with 
perinatal asphyxia had already been observed in previous 
studies [13]. This ambiguity did not allow to categorize some 
newborns as Sarnat stage 1 or 2, but this finding was relevant 
because a quarter of these newborns (all having an abnormal 
early aEEG) progressed to moderate encephalopathy and had 
an abnormal short-term outcome [13]. Nowadays, uncertainty 
in clearly discriminating newborns with mild or moderate 
asphyxia is particularly important as these infants would benefit 
from treatment with hypothermia.
In clinical trials investigating the efficacy of therapeutic 
hypothermia, newborns with mild asphyxia (corresponding to a 
Sarnat grade 1) were excluded from cooling [6–9]. In the CoolCap 
trial, there was anyway a small proportion of included newborns 
with mild asphyxia, and neurological outcome was abnormal in 
a third of them [6]. Both Thoresen et al. [26] and van Handel 
et al. [31] described a group of newborns classified as Sarnat 
grade 1 that were cognitively impaired afterwards. An extensive 
neuropsychological study demonstrated a correlation between 
mild perinatal asphyxia (Sarnat grade 1) and a worst cognitive 
outcome [32]. Currently, evidence to propose cooling for 
neonates with mild asphyxia is insufficient. However, we cannot 
exclude that within the group of newborns with Sarnat 1, there is 
a subgroup exhibiting abnormal aEEG features who could benefit 
from cooling. It is likely that the systematic early utilization of 
aEEG for neonates with any degree of perinatal asphyxia might 
help identifying those, in whom the combined features of early 
neurologic examination and aEEG will facilitate recognition of 
term newborns at risk of persistent encephalopathy [13].
The MRI findings in two of the three additional newborns 
with late neurological disorders and not treated with cooling 
were consistent with signs of infarction. It is likely that this kind 
of disorder might explain why these cases were clinically silent 
initially. In such cases, the aEEG may be an useful tool to ensure a 
prompt diagnosis of cerebral damage. According to our protocol, 
these newborns were not cooled, even if currently it is unknown 
whether cooling after the 6-h treatment window would have been 
beneficial.
If further studies confirm our hypothesis, a precocious aEEG 
analysis should be recommended, and a revision of the entry 
criteria in the current protocol of treatment with hypothermia 
should be applied. When the metabolic criterion is met, the 
hypothermia treatment could be reserved to newborns with 
neurological and/or EEG criteria.
Figure 2. aEEG pattern of patients 1, 2 and 3.
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